For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview of Global Specialty Drug Distribution market:
According to our latest research, the global Specialty Drug Distribution market looks promising in the next 5 years. As of 2022, the global Specialty Drug Distribution market was estimated at USD 1158.12 million, and it's anticipated to reach USD 2259.12 million in 2028, with a CAGR of 11.78% during the forecast years.
Specialty drugs are high-cost prescription drugs used to treat complex chronic diseases such as cancer, rheumatoid arthritis and multiple sclerosis. Specialty Drug Distribution is a link in pharmaceutical logistics. Relying on certain logistics equipment, technology and logistics management information system, the company distributes special drugs to downstream customers. The revenue of Specialty Drug Distribution company mainly comes from the revenue and logistics service fees obtained from wholesale drugs from drug manufacturer and sales to downstream customers such as pharmacies, hospitals, etc. Logistics equipment refers to a series of equipment and tools that drug distribution companies need to use in the process of transporting drugs, including logistics vehicles, shelves, indoor trucks, pallets, turnover boxes, etc. The relying technology includes warehouse management system, electronic label picking system, etc.
Risks of Quality Management of Specialty Drugs
Pharmaceutical distribution and medical health services are specially regulated industries. The governments of various countries have issued relevant policies to strengthen the supervision of the whole process of special drugs, comprehensively increase the penalties for the production and sale of counterfeit and inferior drugs, and stipulate various penalties such as confiscation, fines, orders to suspend production and business for rectification, revocation of licenses, and prohibition of practice measure. Governments of various countries have continuously established and improved the traceability system and pharmacovigilance system for special drugs. Therefore, Specialty Drug Distribution enterprises will face stricter full-cycle and full-process supervision.
As a wholesaler and distributor of special drugs, although the company strictly follows relevant standards, the company conducts audits on procurement qualifications, product acceptance quality, product storage and maintenance, product sales, product delivery reviews, product transportation, and product after-sales services in business activities link quality control. However, since Specialty Drug Distribution is not the manufacturer of the product, it has no control over the quality of the drug's production. At the same time, product quality accidents may also occur in the drug circulation process due to various reasons. Therefore, Specialty Drug Distribution may still have drug quality liability problems during product procurement or sales, which will bring risks to the company's business operations. The risk of quality management of specialty drugs is one of the risks faced by the industry.
Policy change risk
Medicines are special commodities that prevent and treat diseases and protect people's health. The quality of medicines is directly related to people's health and even the survival of their lives. Therefore, it is necessary to ensure the safety, effectiveness and stability of medicines. Therefore, the products handled by the Specialty Drug Distribution enterprise are special commodities. For example, in China, Specialty Drug Distribution enterprises are vulnerable to the influence of relevant national and local policies, especially the influence of medical and health care, medical security, and the reform of the pharmaceutical distribution system. The reform of the three major systems of medical care, medical insurance, and drug supply will profoundly change the pattern of the pharmaceutical distribution field, triggering the differentiation and reorganization of the pharmaceutical market. The business of Specialty Drug Distribution is greatly affected by relevant national policies. Therefore, Specialty Drug Distribution faces certain policy risks.
Region Overview:
In global comparison, a significant portion of the revenue was generated in North America (45.36% in 2022).
Company Overview:
McKesson Corporation is one of the major players operating in the Specialty Drug Distribution market, holding a share of 19.7% in 2022.
McKesson Corporation
McKesson Corporation, a healthcare company. McKesson Corporation partners with biopharmaceutical companies, care providers, pharmacies, manufacturers, governments and others to deliver insights, products and services that make quality care more accessible and affordable. The company specializes in the areas of pharmaceutical distribution, healthcare IT, practice management, supply chain management, medication adherence, pharmacy management, medical supplies, oncology and pharmacy technology.
AmerisourceBergen
AmerisourceBergen is an American pharmaceutical wholesale company. The company provides pharmaceutical sales and related services designed to reduce costs and improve patient outcomes, distributing a range of branded and generic medicines, over-the-counter (OTC), healthcare products and home healthcare supplies and equipment. Clients include urgent care hospitals and health systems, Independent and chain retail pharmacies, mail order facilities, physicians, clinics and other alternate location facilities and skilled nursing and assisted living centers.
Segmentation Overview:
By type, Oncology segment accounted for the largest share of market in 2022.
Oncology
Differentiate according to the types of drugs distributed. Refers to the distribution of specialty medicines for the treatment of Oncology.
Rheumatoid Arthritis
Differentiate according to the types of drugs distributed. Refers to the distribution of specialty medicines for the treatment of Rheumatoid Arthritis.
Multiple Sclerosis
Differentiate according to the types of drugs distributed. Refers to the distribution of specialty medicines for the treatment of Multiple Sclerosis.
Hemophilia
Differentiate according to the types of drugs distributed. Refers to the distribution of specialty medicines used to treat Hemophilia.
Application Overview:
The market's largest segment by application is the segment Clinics, with a market share of 36.06% in 2022.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Specialty Drug Distribution market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global Specialty Drug Distribution Market Report:
Market Size Estimates: Specialty Drug Distribution market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: Specialty Drug Distribution market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Specialty Drug Distribution market
Segment Market Analysis: Specialty Drug Distribution market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: Specialty Drug Distribution market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the Specialty Drug Distribution Market: Revenue and sales volume of major countries in each region
Specialty Drug Distribution Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the Specialty Drug Distribution market in major regions.
Specialty Drug Distribution Industry Value Chain: Specialty Drug Distribution market raw materials & suppliers, manufacturing process, distributors, downstream customers
Specialty Drug Distribution Industry News, Policies & Regulations
Key players in the global Specialty Drug Distribution market are covered in Chapter 12:
Jointown
McKesson Corporation
Max Pharma
Sinopharm
Medipal Holdings
Shanghai Pharma
PHOENIX Pharmahandel GmbH & Co KG
Cardinal Health
CR Pharma
AmerisourceBergen
In Chapter 2 and Chapter 15.1, based on types, the Specialty Drug Distribution market from 2018 to 2028 is primarily split into:
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
In Chapter 3 and Chapter 15.2, based on applications, the Specialty Drug Distribution market from 2018 to 2028 covers:
Retail
Home Health
Clinics
Pharmacies
Hospital
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the Specialty Drug Distribution market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028